Healthtech Days #3 2022

Market Access Strategy for BIOTECH, MEDTECH and DIGITAL HEALTH STARTUPS

FRANCE GERMANY SWITZERLAND

OCTOBER 20 – 21, 2022

BASEL + ONLINE

Key figures of Trinational HealthTech Days #2:

0

Individual meetings between startups & investors/corporates

0

Persons participated to the conferences  

0

Startups (France, Germany, Switzerland) participated to the event

0

Corporates and investors involved in one-on-one meetings

PROGRAM

20th October Day 1
Market access strategy for health products and country particularities
Basel

10.30 Doors open, registration, coffee

 

11.00 Opening remarks & Intro to Tri-National Healthech Days
Speakers: Christian E. Schneider, Head of the Innovation Office, University of Basel ;  Bodo Brückner, Startup Advisor
Coordinator Life Science Accelerator Baden-Wuerttemberg
; Malaika Lauk, Managing Director, BadenCampus ; Guillaume Vetter-Genoud, Head of health department, SEMIA/Quest for change

 

11.15 – 12.15Session 1: The Upper Rhine Life Science Innovation Ecosystem – Leading in Europe

  • Keynote: A tri-national startup success story
    Speaker: Simon Ittig, CEO & Co-Founder, T3 Pharmaceuticals
    • Panel discussion: The best place to do life science innovation in Europe
      Moderator: Felix Früh, Entrepreneur, investor
      Speakers: Jean-Luc Dimarcq, Managing Director, IHU Strasbourg ; Gabriela Güntherodt, Director, Biotech Sector Lead, Switzerland, EY ; Philipp Marchand, Managing Director, Vossius & Partner

13.30 – 15.00 – Session 2: Collaboration with industry – invest (growth of startup)

  • Session A (for medtech startups) – On the journey with MedTech entrepreneurs: pitfalls, learnings and what does it take to be successful
    Moderator: Angélie Pham, Innovation Office University of Basel
    Speakers: Elmar Zurbriggen, CEO, AOT ; Tobias Wilken, CPO, AOT ; Melanie Schäpers, COO, Sefunda ; Christian Zwicky, Deep Breath Intelligence 
  • Session B (for biotech startups) – Dealing with BigPharma or VC from a start-up perspective – When and how? Discussion around hidden challenges, risks and key success factors for a proper partnering readiness – in partnership with Swiss HLG
    Moderator: Zaki Sellam, Serial biotech entrepreneur, Swiss HLG start-up initiative
    Speakers: Sarah Holland, President of Swiss HLG ;  Samantha Brandler, Head of Research Innovation Europe, CSL Behring ; Sara Nunez-Garcia, Co-Founder, Forty51 Ventures, Michael Huebner, Director Early Innovation Partnering, Johnson & Johnson Innovation
  • Session C (for digital health startups) – The digital transition: How startups can help established corporations and established corporations help startups?
    Speakers: Greg Nelson, Project Manager Aesculap M&A/external Innovation, Innovation Hub, B. Braun ; Murat Akturk, Global Growth Director, Edison for Enterprise, GE HealthCare ; Christoph Wagner, CEO WBG Holding & Karsten Sternberg, Senior Advisor Medipee ; Bastian Deck, CEO & Founder NOVAZOON & Steffen Bäumler, CPO MAEX
 

15.00 – 15.15 Closing, learnings & Call to Action

 

15.15 – 17.00 Networking & Apero

Christian E. Schneider
Head of the Innovation Office, University of Basel

Bodo Brückner
Startup Advisor Coordinator, Life Science Accelerator Baden-Wurttemberg

Malaika Lauk
Managing Director, BadenCampus

Guillaume Vetter-Genoud
Head of health department, SEMIA/Quest for change

Simon Ittig
CEO, T3 Pharmaceuticals

Jean Luc Dimarcq
Managing Director, IHU Strasbourg

Gabriela Güntherodt
Director BioTech Sector Lead, CH, EY

Philipp Marchand
Managing Director, Vossius & Partner

Elmar Zurbriggen
CEO, AOT

Tobias Wilken
CPO, AOT

Mélanie Schäpers
COO, Sefunda

Christian Zwicky
CEO, Deep Breath Intelligence

Zaki Sellam
Serial biotech entrepreneur, Swiss HLG start-up initiative

Sarah Holland
President of Swiss HLG

Samantha Brandler
Head of research Innovation Europe / CSL Behring

Sara Nunez-Garcia
Co-founder, Forty51 Ventures

Michael Huebner
Director Early Innovation Partnering
Johnson & Johnson Innovation

Greg Nelson
Project Manager , B. Braun

Murat Akturk
Global Growth Director, GE HealthCare

Christoph Wagner
CEO, WBG Holding

Karsten Sternberg
Senior Advisor, Medipee

Bastian Deck
CEO & Founder, NOVAZOON

Steffen Bäumler
CPO, MAEX

21th October – Day 2
One-on-One meetings of startups and investors/corporates
Online

13.00 – 13.15 : Opening & Instructions

13.15 – 16.00 : One-on-One sessions

VENTURE CAPITAL

CORPORATES